the gelling fbre dressing - molnlycke.ae · 8 10 4,5 6 . exufber ® range. the gelling fbre...
Post on 12-Feb-2019
219 Views
Preview:
TRANSCRIPT
The gelling fbre dressing you would design
Easy removal Superior fuid retention Rapid antimicrobial action Breaks down bioflm
Applicable to Exufberreg Ag+ only
We discovered ldquoWe went through hundreds of prototypes
before arriving at the fnal design that gelling fbre The clinical results proved that we had created something specialrdquo
Erik Carlsson Moumllnlycke Research amp Development dressings could perform even better At Moumllnlyckereg we have carried out a multinational survey asking more than 500 clinicians about their day to day challenges when treating wounds with gelling fbre dressings The results show that current alternatives leave much to be desired
said their current said that managing gelling fbre More leakage and
More than dressing broke up maceration were during removal1 than half key challenges1
1 in 3
Exudate management is a balancing act When it comes to exudate management gelling fbre dressings must do more than absorb fuid They must also retain that fuid when compressed Otherwise fuid could leak out and cause moisture-related skin damage
Gelling fbre dressings must balance these four characteristics
Absorption
Wet strength
Fluid retention
Conformability
Exufberregrange The gelling fbre dressings you would design Combining antimicrobial action with clean easy removal and reduced risk of skin damage
Clean easy removal2 Reduced risk of skin damage3 Reduced risk of infection6ndash10
High wet tensile strength means the dressings Leakage can lead to skin damage such as maceration bull Provides rapid antimicrobial action that lasts up to 7 days (in vitro)6 stay intact on removal leaving no dressing Exufberrsquos superior retention45 reduces the risk of bull Works against a broad range of pathogens including VRE and MRSA (in vitro)6 residue in the wound bed leakage even when the dressing is compressed bull Provides an effective barrier against bacterial penetration (in vitro)7
bull Proven to kill 99 of mould within 24 hours (in vitro)8 bull Effective against bioflm9 bull May reduce odour10 Applicable to Exufber Ag+ only
Reduced risk of skin damage2ndash3 Hydrolockreg
Leakage can lead to skin damage such as 100
Technology maceration Exufberrsquos superior retention 95reduces the risk of leakage even when the
dressing is compressed 90
85
80
75
70
65
60
Exufberreg dressings retain 23 more fuid than Aquacelreg Ag Extra5
r
eten
tion
Gelling fbre dressings reinvented
Exufber dressings are made using a patented processing method with a different material from traditional gelling fbres This is Hydrolockreg Technology locking in fuid and harmful bacteria and balancing the key features you expect in a
Aquacelreg Ag Extra Exufberreg Ag+ gelling fbre dressing
The silver effect Exufber Ag+ contains fne
silver sulphate that is evenly distributed in the dressing Contact with fuid initiates a controlled release of silver
ions that work against pathogens
Bacterial counts (CFU) 10
of Pseudomonas 9
aeruginosa bioflm 8 after treatment9
7
Exufberreg Ag+
Log
CF
Ug
6
5
4
3
Baseline Day 3 Day 5 Day 7
Aquacelreg gelling fbre dressing
Viewed under a microscope you can see that Exufber dressing is packed full of tightly entangled fbres that minimize the free space for fuid or exudate to fow which in turn boosts the entire dressingrsquos integrity The result is excellent tensile strength for easy removal and superior fuid retention to minimize the risk of leakage and maceration
2 Aquacelreg Ag+ Extra
1
Untreated control 0
Superior antibioflm action
Bioflms are clusters of bacteria that are resistant to prevent healing11 In vivo data shows that Exufber Ag+ treatment and the bodyrsquos natural defences It has been is signifcantly better at breaking down bioflm shown that bioflm may be present in up to 100 of compared to Aquacelreg Ag+ Extra9
chronic wounds and that bioflm may delay or even Applicable to Exufber Ag+ only
Exufberreg gelling fbre dressing
with Hydrolockreg Technology with Hydrolockreg Technology
The gelling fbre dressings you would design
Superior retention458 Antimicrobial action against broad range of
Easy removal2 pathogens including VRE MRSA and mould68
Sustained antimicrobial action68 Breaks down bioflm in vivo9
May reduce odour10
Tested in vitro and applicable for Exufber Ag+ only
Exufber Ag+ ordering information Exufber ordering information
Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont
603421 5 x 5 10 40 603300 5 x 5 10 40
603425 10 x 10 10 60 603301 10 x 10 10 60
603422 10 x 12 10 60 603302 15 x 15 10 60
603423 15 x 15 10 60 603303 20 x 30 5 20
603424 20 x 30 5 20 603304 2 x 50 5 20
603420 2 x 45 5 20
REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm
Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007
Aquacelreg is registered trademark of ConvaTec Inc
We discovered ldquoWe went through hundreds of prototypes
before arriving at the fnal design that gelling fbre The clinical results proved that we had created something specialrdquo
Erik Carlsson Moumllnlycke Research amp Development dressings could perform even better At Moumllnlyckereg we have carried out a multinational survey asking more than 500 clinicians about their day to day challenges when treating wounds with gelling fbre dressings The results show that current alternatives leave much to be desired
said their current said that managing gelling fbre More leakage and
More than dressing broke up maceration were during removal1 than half key challenges1
1 in 3
Exudate management is a balancing act When it comes to exudate management gelling fbre dressings must do more than absorb fuid They must also retain that fuid when compressed Otherwise fuid could leak out and cause moisture-related skin damage
Gelling fbre dressings must balance these four characteristics
Absorption
Wet strength
Fluid retention
Conformability
Exufberregrange The gelling fbre dressings you would design Combining antimicrobial action with clean easy removal and reduced risk of skin damage
Clean easy removal2 Reduced risk of skin damage3 Reduced risk of infection6ndash10
High wet tensile strength means the dressings Leakage can lead to skin damage such as maceration bull Provides rapid antimicrobial action that lasts up to 7 days (in vitro)6 stay intact on removal leaving no dressing Exufberrsquos superior retention45 reduces the risk of bull Works against a broad range of pathogens including VRE and MRSA (in vitro)6 residue in the wound bed leakage even when the dressing is compressed bull Provides an effective barrier against bacterial penetration (in vitro)7
bull Proven to kill 99 of mould within 24 hours (in vitro)8 bull Effective against bioflm9 bull May reduce odour10 Applicable to Exufber Ag+ only
Reduced risk of skin damage2ndash3 Hydrolockreg
Leakage can lead to skin damage such as 100
Technology maceration Exufberrsquos superior retention 95reduces the risk of leakage even when the
dressing is compressed 90
85
80
75
70
65
60
Exufberreg dressings retain 23 more fuid than Aquacelreg Ag Extra5
r
eten
tion
Gelling fbre dressings reinvented
Exufber dressings are made using a patented processing method with a different material from traditional gelling fbres This is Hydrolockreg Technology locking in fuid and harmful bacteria and balancing the key features you expect in a
Aquacelreg Ag Extra Exufberreg Ag+ gelling fbre dressing
The silver effect Exufber Ag+ contains fne
silver sulphate that is evenly distributed in the dressing Contact with fuid initiates a controlled release of silver
ions that work against pathogens
Bacterial counts (CFU) 10
of Pseudomonas 9
aeruginosa bioflm 8 after treatment9
7
Exufberreg Ag+
Log
CF
Ug
6
5
4
3
Baseline Day 3 Day 5 Day 7
Aquacelreg gelling fbre dressing
Viewed under a microscope you can see that Exufber dressing is packed full of tightly entangled fbres that minimize the free space for fuid or exudate to fow which in turn boosts the entire dressingrsquos integrity The result is excellent tensile strength for easy removal and superior fuid retention to minimize the risk of leakage and maceration
2 Aquacelreg Ag+ Extra
1
Untreated control 0
Superior antibioflm action
Bioflms are clusters of bacteria that are resistant to prevent healing11 In vivo data shows that Exufber Ag+ treatment and the bodyrsquos natural defences It has been is signifcantly better at breaking down bioflm shown that bioflm may be present in up to 100 of compared to Aquacelreg Ag+ Extra9
chronic wounds and that bioflm may delay or even Applicable to Exufber Ag+ only
Exufberreg gelling fbre dressing
with Hydrolockreg Technology with Hydrolockreg Technology
The gelling fbre dressings you would design
Superior retention458 Antimicrobial action against broad range of
Easy removal2 pathogens including VRE MRSA and mould68
Sustained antimicrobial action68 Breaks down bioflm in vivo9
May reduce odour10
Tested in vitro and applicable for Exufber Ag+ only
Exufber Ag+ ordering information Exufber ordering information
Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont
603421 5 x 5 10 40 603300 5 x 5 10 40
603425 10 x 10 10 60 603301 10 x 10 10 60
603422 10 x 12 10 60 603302 15 x 15 10 60
603423 15 x 15 10 60 603303 20 x 30 5 20
603424 20 x 30 5 20 603304 2 x 50 5 20
603420 2 x 45 5 20
REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm
Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007
Aquacelreg is registered trademark of ConvaTec Inc
Exufberregrange The gelling fbre dressings you would design Combining antimicrobial action with clean easy removal and reduced risk of skin damage
Clean easy removal2 Reduced risk of skin damage3 Reduced risk of infection6ndash10
High wet tensile strength means the dressings Leakage can lead to skin damage such as maceration bull Provides rapid antimicrobial action that lasts up to 7 days (in vitro)6 stay intact on removal leaving no dressing Exufberrsquos superior retention45 reduces the risk of bull Works against a broad range of pathogens including VRE and MRSA (in vitro)6 residue in the wound bed leakage even when the dressing is compressed bull Provides an effective barrier against bacterial penetration (in vitro)7
bull Proven to kill 99 of mould within 24 hours (in vitro)8 bull Effective against bioflm9 bull May reduce odour10 Applicable to Exufber Ag+ only
Reduced risk of skin damage2ndash3 Hydrolockreg
Leakage can lead to skin damage such as 100
Technology maceration Exufberrsquos superior retention 95reduces the risk of leakage even when the
dressing is compressed 90
85
80
75
70
65
60
Exufberreg dressings retain 23 more fuid than Aquacelreg Ag Extra5
r
eten
tion
Gelling fbre dressings reinvented
Exufber dressings are made using a patented processing method with a different material from traditional gelling fbres This is Hydrolockreg Technology locking in fuid and harmful bacteria and balancing the key features you expect in a
Aquacelreg Ag Extra Exufberreg Ag+ gelling fbre dressing
The silver effect Exufber Ag+ contains fne
silver sulphate that is evenly distributed in the dressing Contact with fuid initiates a controlled release of silver
ions that work against pathogens
Bacterial counts (CFU) 10
of Pseudomonas 9
aeruginosa bioflm 8 after treatment9
7
Exufberreg Ag+
Log
CF
Ug
6
5
4
3
Baseline Day 3 Day 5 Day 7
Aquacelreg gelling fbre dressing
Viewed under a microscope you can see that Exufber dressing is packed full of tightly entangled fbres that minimize the free space for fuid or exudate to fow which in turn boosts the entire dressingrsquos integrity The result is excellent tensile strength for easy removal and superior fuid retention to minimize the risk of leakage and maceration
2 Aquacelreg Ag+ Extra
1
Untreated control 0
Superior antibioflm action
Bioflms are clusters of bacteria that are resistant to prevent healing11 In vivo data shows that Exufber Ag+ treatment and the bodyrsquos natural defences It has been is signifcantly better at breaking down bioflm shown that bioflm may be present in up to 100 of compared to Aquacelreg Ag+ Extra9
chronic wounds and that bioflm may delay or even Applicable to Exufber Ag+ only
Exufberreg gelling fbre dressing
with Hydrolockreg Technology with Hydrolockreg Technology
The gelling fbre dressings you would design
Superior retention458 Antimicrobial action against broad range of
Easy removal2 pathogens including VRE MRSA and mould68
Sustained antimicrobial action68 Breaks down bioflm in vivo9
May reduce odour10
Tested in vitro and applicable for Exufber Ag+ only
Exufber Ag+ ordering information Exufber ordering information
Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont
603421 5 x 5 10 40 603300 5 x 5 10 40
603425 10 x 10 10 60 603301 10 x 10 10 60
603422 10 x 12 10 60 603302 15 x 15 10 60
603423 15 x 15 10 60 603303 20 x 30 5 20
603424 20 x 30 5 20 603304 2 x 50 5 20
603420 2 x 45 5 20
REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm
Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007
Aquacelreg is registered trademark of ConvaTec Inc
Reduced risk of skin damage2ndash3 Hydrolockreg
Leakage can lead to skin damage such as 100
Technology maceration Exufberrsquos superior retention 95reduces the risk of leakage even when the
dressing is compressed 90
85
80
75
70
65
60
Exufberreg dressings retain 23 more fuid than Aquacelreg Ag Extra5
r
eten
tion
Gelling fbre dressings reinvented
Exufber dressings are made using a patented processing method with a different material from traditional gelling fbres This is Hydrolockreg Technology locking in fuid and harmful bacteria and balancing the key features you expect in a
Aquacelreg Ag Extra Exufberreg Ag+ gelling fbre dressing
The silver effect Exufber Ag+ contains fne
silver sulphate that is evenly distributed in the dressing Contact with fuid initiates a controlled release of silver
ions that work against pathogens
Bacterial counts (CFU) 10
of Pseudomonas 9
aeruginosa bioflm 8 after treatment9
7
Exufberreg Ag+
Log
CF
Ug
6
5
4
3
Baseline Day 3 Day 5 Day 7
Aquacelreg gelling fbre dressing
Viewed under a microscope you can see that Exufber dressing is packed full of tightly entangled fbres that minimize the free space for fuid or exudate to fow which in turn boosts the entire dressingrsquos integrity The result is excellent tensile strength for easy removal and superior fuid retention to minimize the risk of leakage and maceration
2 Aquacelreg Ag+ Extra
1
Untreated control 0
Superior antibioflm action
Bioflms are clusters of bacteria that are resistant to prevent healing11 In vivo data shows that Exufber Ag+ treatment and the bodyrsquos natural defences It has been is signifcantly better at breaking down bioflm shown that bioflm may be present in up to 100 of compared to Aquacelreg Ag+ Extra9
chronic wounds and that bioflm may delay or even Applicable to Exufber Ag+ only
Exufberreg gelling fbre dressing
with Hydrolockreg Technology with Hydrolockreg Technology
The gelling fbre dressings you would design
Superior retention458 Antimicrobial action against broad range of
Easy removal2 pathogens including VRE MRSA and mould68
Sustained antimicrobial action68 Breaks down bioflm in vivo9
May reduce odour10
Tested in vitro and applicable for Exufber Ag+ only
Exufber Ag+ ordering information Exufber ordering information
Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont
603421 5 x 5 10 40 603300 5 x 5 10 40
603425 10 x 10 10 60 603301 10 x 10 10 60
603422 10 x 12 10 60 603302 15 x 15 10 60
603423 15 x 15 10 60 603303 20 x 30 5 20
603424 20 x 30 5 20 603304 2 x 50 5 20
603420 2 x 45 5 20
REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm
Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007
Aquacelreg is registered trademark of ConvaTec Inc
with Hydrolockreg Technology with Hydrolockreg Technology
The gelling fbre dressings you would design
Superior retention458 Antimicrobial action against broad range of
Easy removal2 pathogens including VRE MRSA and mould68
Sustained antimicrobial action68 Breaks down bioflm in vivo9
May reduce odour10
Tested in vitro and applicable for Exufber Ag+ only
Exufber Ag+ ordering information Exufber ordering information
Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont
603421 5 x 5 10 40 603300 5 x 5 10 40
603425 10 x 10 10 60 603301 10 x 10 10 60
603422 10 x 12 10 60 603302 15 x 15 10 60
603423 15 x 15 10 60 603303 20 x 30 5 20
603424 20 x 30 5 20 603304 2 x 50 5 20
603420 2 x 45 5 20
REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm
Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007
Aquacelreg is registered trademark of ConvaTec Inc
top related